Screening of New Drug Targets against Respiratory Syncytial Virus Infection

ZHOU Qing,LUO Zhi,ZHAO Dongchi,MA Lei,WEI Lai,LI Lei
DOI: https://doi.org/10.3969/j.issn.1008-987x.2013.06.07
2013-01-01
Abstract:Objective To screen potential targets for anti- RSV drugs,we constructed the pSUPER RNAi vectors of targeting gene in infection of RSV on SPC- A1 cell in order to inhibit the replication of RSV at gene level. Methods Use DDRT- PCR method to obtain mRNA differential expression spectrum of SPC- A1 cell infected by RSV,then gain more than thirty genes which are close correlation in in- fection of RSV using electronic clone. We selected some gene sequences as target spot among the thirty genes. Sixty four base- pair oligos for hairpin RNA expression were chemically synthesized and annealed. PSUPER vector was linearized with BglII and HindⅢ. Finally,annealed oligos were inserted into the treated pSUPER to construct RNAi plasmid. Then active recombinant plasmids were selected primarily and the transfection efficiency,cytotoxicity were evaluated. We make use of Plaque assay and the MTT method to observe disturbing effection of four recombinant plasmids and specific inhibit effction of corresponding virus target gene. Results Four recombinant plasmids pshRNA- ZQ06 / 16 /20 /26 targeting the gene of RSV successfully constructed,and they could alleviated the CPE of RSV infectied SPC- A1cells. The recom- binant plasmids had not significant cytotoxicity on SPC- A1 cells. By the method of MTT,analysing and determing the effection of RNAi that can specific inhibit RSV target gene. Conclusions The pshRNA- ZQ06 /20 /26 showed a more potent inhibition than pshRNA- ZQ16.
What problem does this paper attempt to address?